0

Arg-Gly-Asp-Ser

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP91037659
CAS91037-65-9
MDL NumberMFCD00076452
Molecular Weight433.42
InChI KeyNNRFRJQMBSBXGO-CIUDSAMLSA-N
Description≥95% (HPLC)
Assay≥95% (HPLC)
Size2MG, 5MG, 10MG
Storage Conditions−20°C
1

An Arg-Gly-Asp-directed Receptor on the Surface of Human Melanoma Cells Exists in an Divalent Cation-Dependent Functional Complex With the Disialoganglioside GD2

D A Cheresh, R Pytela, M D Pierschbacher, F G Klier, E Ruoslahti, R A Reisfeld

J Cell Biol. 1987 Sep;105(3):1163-73.

PMID: 2443507

1

Arg-Gly-Asp-Ser (RGDS) Peptide Stimulates Transforming Growth Factor beta1 Transcription and Secretion Through Integrin Activation

R Ortega-Velázquez, M L Díez-Marqués, M P Ruiz-Torres, M González-Rubio, M Rodríguez-Puyol, D Rodríguez Puyol

FASEB J. 2003 Aug;17(11):1529-31.

PMID: 12824296

1

Arg-Gly-Asp-Ser Peptide Analogs Suppress Cartilage Chondrolytic Activities of Integrin-Binding and Nonbinding Fibronectin Fragments

G A Homandberg, F Hui

Arch Biochem Biophys. 1994 Apr;310(1):40-8.

PMID: 8161219

1

Arg-Gly-Asp-Ser-selective Adhesion and the Stabilization of Long-Term Potentiation: Pharmacological Studies and the Characterization of a Candidate Matrix Receptor

B A Bahr, U Staubli, P Xiao, D Chun, Z X Ji, E T Esteban, G Lynch

J Neurosci. 1997 Feb 15;17(4):1320-9.

PMID: 9006975

1

The Effect of Arg-Gly-Asp-containing Peptides on Fibrinogen and Von Willebrand Factor Binding to Platelets

E F Plow, M D Pierschbacher, E Ruoslahti, G A Marguerie, M H Ginsberg

Proc Natl Acad Sci U S A. 1985 Dec;82(23):8057-61.

PMID: 3877935

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode